Annual EBIT
-$164.16 M
-$33.51 M-25.65%
December 31, 2023
Summary
- As of February 7, 2025, AVIR annual earnings before interest & taxes is -$164.16 million, with the most recent change of -$33.51 million (-25.65%) on December 31, 2023.
- During the last 3 years, AVIR annual EBIT has fallen by -$153.13 million (-1388.32%).
- AVIR annual EBIT is now -218.63% below its all-time high of $138.38 million, reached on December 31, 2021.
Performance
AVIR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$37.20 M
+$9.71 M+20.71%
September 30, 2024
Summary
- As of February 7, 2025, AVIR quarterly earnings before interest & taxes is -$37.20 million, with the most recent change of +$9.71 million (+20.71%) on September 30, 2024.
- Over the past year, AVIR quarterly EBIT has increased by +$3.58 million (+8.79%).
- AVIR quarterly EBIT is now -130.70% below its all-time high of $121.18 million, reached on December 31, 2021.
Performance
AVIR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$200.50 M
+$3.58 M+1.76%
September 30, 2024
Summary
- As of February 7, 2025, AVIR TTM earnings before interest & taxes is -$200.50 million, with the most recent change of +$3.58 million (+1.76%) on September 30, 2024.
- Over the past year, AVIR TTM EBIT has dropped by -$43.01 million (-27.31%).
- AVIR TTM EBIT is now -244.89% below its all-time high of $138.38 million, reached on December 31, 2021.
Performance
AVIR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AVIR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.6% | +8.8% | -27.3% |
| 3 y3 years | -1388.3% | +8.8% | -27.3% |
| 5 y5 years | -1632.2% | +8.8% | -27.3% |
AVIR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -218.6% | at low | -130.7% | +46.7% | -244.9% | +1.8% |
| 5 y | 5-year | -218.6% | at low | -130.7% | +46.7% | -244.9% | +1.8% |
| alltime | all time | -218.6% | at low | -130.7% | +46.7% | -244.9% | +1.8% |
Atea Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$37.20 M(-20.7%) | -$200.50 M(-1.8%) |
| Jun 2024 | - | -$46.92 M(-32.8%) | -$204.08 M(+6.1%) |
| Mar 2024 | - | -$69.81 M(+49.9%) | -$192.40 M(+17.2%) |
| Dec 2023 | -$164.16 M(+25.7%) | -$46.57 M(+14.2%) | -$164.16 M(+4.2%) |
| Sep 2023 | - | -$40.78 M(+15.8%) | -$157.49 M(+18.4%) |
| Jun 2023 | - | -$35.23 M(-15.2%) | -$132.98 M(+2.3%) |
| Mar 2023 | - | -$41.57 M(+4.2%) | -$130.04 M(-0.5%) |
| Dec 2022 | -$130.65 M(-194.4%) | -$39.90 M(+145.1%) | -$130.65 M(-529.3%) |
| Sep 2022 | - | -$16.28 M(-49.6%) | $30.43 M(+23.9%) |
| Jun 2022 | - | -$32.30 M(-23.4%) | $24.56 M(-62.5%) |
| Mar 2022 | - | -$42.17 M(-134.8%) | $65.55 M(-52.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $138.38 M(-1354.6%) | $121.18 M(-647.2%) | $138.38 M(+265.7%) |
| Sep 2021 | - | -$22.15 M(-354.9%) | $37.84 M(-10.7%) |
| Jun 2021 | - | $8.69 M(-71.7%) | $42.36 M(+79.0%) |
| Mar 2021 | - | $30.66 M(+48.5%) | $23.67 M(-314.6%) |
| Dec 2020 | -$11.03 M(-24.5%) | $20.65 M(-217.1%) | -$11.03 M(-69.7%) |
| Sep 2020 | - | -$17.63 M(+76.2%) | -$36.43 M(+61.4%) |
| Jun 2020 | - | -$10.00 M(+147.3%) | -$22.57 M(+79.6%) |
| Mar 2020 | - | -$4.04 M(-14.8%) | -$12.56 M(+47.5%) |
| Dec 2019 | -$14.61 M(+54.1%) | -$4.75 M(+26.0%) | -$8.52 M(+126.0%) |
| Sep 2019 | - | -$3.77 M | -$3.77 M |
| Dec 2018 | -$9.48 M | - | - |
FAQ
- What is Atea Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals annual EBIT year-on-year change?
- What is Atea Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals quarterly EBIT year-on-year change?
- What is Atea Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals TTM EBIT year-on-year change?
What is Atea Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of AVIR is -$164.16 M
What is the all time high annual EBIT for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high annual earnings before interest & taxes is $138.38 M
What is Atea Pharmaceuticals annual EBIT year-on-year change?
Over the past year, AVIR annual earnings before interest & taxes has changed by -$33.51 M (-25.65%)
What is Atea Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of AVIR is -$37.20 M
What is the all time high quarterly EBIT for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high quarterly earnings before interest & taxes is $121.18 M
What is Atea Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, AVIR quarterly earnings before interest & taxes has changed by +$3.58 M (+8.79%)
What is Atea Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of AVIR is -$200.50 M
What is the all time high TTM EBIT for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high TTM earnings before interest & taxes is $138.38 M
What is Atea Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, AVIR TTM earnings before interest & taxes has changed by -$43.01 M (-27.31%)